These genes include KRAS, FCGBP, NRAS, DNM3, SSC5D, TCHH, and ZNF99. Because tumor samples with DNM3 mutations had higher tumor DNA purity and VAF, we validated these mutations using Sanger sequencing (Additional file 1: Fig. S2). This evidence concerns the gene FCGBP and neoplasm.